Return to content in this issue
Successful subcutaneous desensitization to certolizumab
Peñalver MJ MD, Bautista-Villanueva S MD, Barranco R MD, Crespo JF MD PhD, Mielgo R MD
Allergy Department, Hospital Universitario 12 de Octubre, Madrid, Spain
J Investig Allergol Clin Immunol 2024; Vol. 34(4)
doi: 10.18176/jiaci.0981
Key words: TNFα inhibitor, Certolizumab, Hypersensitivity, Desensitization, Allergy